kappa-Opioid receptor in humans: cDNA and genomic cloning, chromosomal assignment, functional expression, pharmacology, and expression pattern in the central nervous system.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1995-07-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.92.15.7006PMID 7624359PMCID PMC41460
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNA probe localization at 18p113 band by in situ hybridization and identification of a small supernumerary chromosome

  2004cited by this paper
• Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors.

  1994cited by this paper
• Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene.

  1994cited by this paper
• Primary structure and functional expression of a guinea pig kappa opioid (dynorphin) receptor.

  1994cited by this paper
• Localization of the kappa opioid receptor gene to human chromosome band 8q11.2.

  1994cited by this paper
• Human mu opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment.

  1994cited by this paper
• Isolation of a human kappa opioid receptor cDNA from placenta.

  1994cited by this paper
• Distribution of kappa opioid receptor mRNA in adult mouse brain: an in situ hybridization histochemistry study.

  1994cited by this paper
• The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain.

  1994cited by this paper
• Molecular cloning and functional expression of a mu-opioid receptor from rat brain.

  1993cited by this paper
• Endogenous opiates: 1992.

  1993cited by this paper
• Molecular cloning of a rat kappa opioid receptor reveals sequence similarities to the mu and delta opioid receptors.

  1993cited by this paper
• Molecular cloning and expression of a rat kappa opioid receptor.

  1993cited by this paper
• Cloning and pharmacological characterization of a rat kappa opioid receptor.

  1993cited by this paper
• Cloning and functional comparison of kappa and delta opioid receptors from mouse brain.

  1993cited by this paper
• Cloning and expression of a cDNA for the rat kappa-opioid receptor.

  1993cited by this paper
• cDNA cloning and pharmacological characterization of an opioid receptor with high affinities for κ‐subtype‐selective ligands

  1993cited by this paper
• Cloning of a delta opioid receptor by functional expression.

  1992cited by this paper
• The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization.

  1992cited by this paper
• Kappa-opioid receptors and analgesia.

  1990cited by this paper
• Multiple opioid receptors: ligand selectivity profiles and binding site signatures.

  1989cited by this paper
• The kappa-opioid receptor from human placenta: hydrodynamic characteristics and evidence for its association with a G protein.

  1988cited by this paper
• Opiate receptors in the human spinal cord: a detailed anatomical study comparing the autoradiographic localization of [3H]diprenorphine binding sites with the laminar pattern of substance P, myelin and nissl staining.

  1987cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain.

  1981cited by this paper

• κ-opioid receptor: from analgesic target to neuroimmune hub

  2026cites this paper
• Effects of Biased Analogues of the Kappa Opioid Receptor Agonist, U50,488, in Preclinical Models of Pain and Side Effects

  2025cites this paper
• Opioid receptors in GtoPdb v.2025.3

  2025cites this paper
• Opioid Receptor Signaling Throughout Ontogeny: Shaping Neural and Behavioral Trajectories.

  2025cites this paper
• Opioid receptors in GtoPdb v.2025.1

  2025cites this paper
• Intestinal immunoglobulins under microbial dysbiosis: implications in opioid-induced microbial dysbiosis

  2025cites this paper
• Kappa opioid receptor control of motivated behavior revisited

  2025cites this paper
• κ-Opioid Receptor Agonists as Robust Pain-Modulating Agents: Mechanisms and Therapeutic Potential in Pain Modulation

  2025cites this paper
• Nalfurafine promotes myelination in vitro and facilitates recovery from cuprizone + rapamycin‐induced demyelination in mice

  2024cites this paper
• De novo generation of dual-target compounds using artificial intelligence

  2024cites this paper
• Interactions Between Endogenous Opioids and the Immune System.

  2024cites this paper
• Predicting therapeutic and side effects from drug binding affinities to human proteome structures

  2024cites this paper
• Semisynthetic guanidino lipoglycopeptides with potent in vitro and in vivo antibacterial activity

  2024cites this paper
• Baicalein isolated from Oroxylum indicum acts as a potent µ- and κ-opioid receptor antagonist agent via the reversal of agonist-mediated cAMP inhibition

  2024cites this paper
• Limitations and potential of κOR biased agonists for pain and itch management

  2024cites this paper
• Opioid receptors in GtoPdb v.2023.1 Opioid receptors in GtoPdb v.2023.1

  2023cites this paper
• Preclinical Models of Attention Deficit Hyperactivity Disorder: Neurobiology, Drug Discovery, and Beyond

  2023cites this paper
• Cocaine self-administration augments kappa opioid receptor system-mediated inhibition of dopamine activity in the mesolimbic dopamine system

  2023cites this paper
• The role of opioid receptors in modulating Alzheimer’s Disease

  2023cites this paper
• The Role of the Endogenous Opioid System in the Vocal Behavior of Songbirds and Its Possible Role in Vocal Learning

  2022cites this paper
• The apelin/APJ signaling system and cytoprotection: Role of its cross-talk with kappa opioid receptor.

  2022cites this paper
• Pharmacology of Kappa Opioid Receptors: Novel Assays and Ligands

  2022cites this paper
• Identification and Validation of Inflammatory Response-Related Gene Signatures to Predict the Prognosis of Neuroblastoma

  2022cites this paper
• Dynorphin/Kappa-Opioid Receptor System Modulation of Cortical Circuitry.

  2021cites this paper
• Pituitary neuropeptides and B lymphocyte function

  2021cites this paper
• Adult-Attention Deficit Hyperactive Disorder Symptoms Seem Not to Influence the Outcome of an Enhanced Agonist Opioid Treatment: A 30-Year Follow-Up

  2021cites this paper
• κ-opioid receptor agonist U50488H attenuates postoperative cognitive dysfunction of cardiopulmonary bypass rats through the PI3K/AKT/Nrf2/HO-1 pathway

  2021cites this paper
• Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating disease

  2021cites this paper
• NB-33, a bioreversible opioid derivative of Nalbuphine, shows enhanced pharmacodynamics.

  2021cites this paper
• Functional Constructivism Approach to Multilevel Nature of Bio-Behavioral Diversity

  2021cites this paper
• The Kappa Opioid Receptor System in Temporal Lobe Epilepsy.

  2021cites this paper
• Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine

  2021cites this paper
• Fundamentals of the Dynorphins/Kappa Opioid Receptor System: From Distribution to Signaling and Function.

  2021cites this paper
• Opioids in cancer: The κ-opioid receptor

  2021cites this paper
• Contingent Tunes of Neurochemical Ensembles in the Norm and Pathology: Can We See the Patterns?

  2021cites this paper
• Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS)

  2020cites this paper
• The Continuum from Temperament to Mental Illness: Dynamical Perspectives

  2020cites this paper
• Pleiotropic Effects of Kappa Opioid Receptor-Related Ligands in Non-human Primates.

  2020cites this paper
• Biased Ligands at the Kappa Opioid Receptor: Fine-Tuning Receptor Pharmacology.

  2020cites this paper
• Opioid Receptors in Immune and Glial Cells—Implications for Pain Control

  2020cites this paper
• Pain‐induced alterations in the dynorphinergic system within the mesocorticolimbic pathway: Implication for alcohol addiction

  2020cites this paper
• Strategies for Developing κ Opioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects

  2020cites this paper
• Frontal Cortical Monoamine Release, Attention, and Working Memory in a Perinatal Nicotine Exposure Mouse Model Following Kappa Opioid Receptor Antagonism.

  2020cites this paper
• Targeting opioid dysregulation in depression for the development of novel therapeutics.

  2019cites this paper
• Social status and demographic effects of the kappa opioid receptor: a PET imaging study with a novel agonist radiotracer in healthy volunteers

  2019cites this paper
• Structure and dynamics of dynorphin peptide and its receptor.

  2019cites this paper
• Novel Drug-Like Somatostatin Receptor 4 Agonists are Potential Analgesics for Neuropathic Pain

  2019cites this paper
• Development and In Vivo Evaluation of a κ-Opioid Receptor Agonist as a PET Radiotracer with Superior Imaging Characteristics

  2019cites this paper
• Design and Synthesis of a Novel and Selective Kappa Opioid Receptor (KOR) Antagonist (BTRX-335140).

  2019cites this paper
• Efecto del extracto de Salvia divinorum en el consumo de alcohol en ratas

  2019cites this paper
• Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders

  2019cites this paper
• Short-term withdrawal from repeated exposure to cocaine during adolescence modulates dynorphin mRNA levels and BDNF signaling in the rat nucleus accumbens.

  2019cites this paper
• A Survey of Molecular Imaging of Opioid Receptors

  2019cites this paper
• Members of the same pharmacological family are not alike: Different opioids, different consequences, hope for the opioid crisis?

  2019cites this paper
• Opioid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Investigating the anti-cocaine, anti-nociceptive properties and side effects of MP1104, a novel mixed opioid receptor agonist

  2019influential citation
• G protein signaling–biased agonism at the κ-opioid receptor is maintained in striatal neurons

  2018cites this paper
• Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol.

  2018cites this paper
• Discrepancies in Kappa Opioid Agonist Binding Revealed through PET Imaging.

  2018cites this paper
• Investigating the antinociceptive effects of N-docosahexaenoyl ethanolamine and novel kappa opioid receptor agonists

  2018cites this paper
• Advances in Achieving Opioid Analgesia Without Side Effects

  2018cites this paper
• Role of dorsal hippocampus &kgr; opioid receptors in contextual aversive memory consolidation in rats

  2018cites this paper
• Stress-induced modulation of pain: Role of the endogenous opioid system.

  2018cites this paper
• Effects of opioid‐ and non‐opioid analgesics on responses to psychosocial stress in humans

  2018cites this paper
• Novel KOR Antidepressant and Analgesic Strategies

  2018cites this paper
• Glycosylation and dimerization of the human δ-opioid receptor polymorphic variants

  2018cites this paper
• Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.

  2017cites this paper
• Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential?

  2016cites this paper
• Benefits of Distinguishing between Physical and Social-Verbal Aspects of Behavior: An Example of Generalized Anxiety

  2016cites this paper
• Alterations in the Neurotransmitter Receptor Binding Densities in Cloninger Type 1 and 2 Alcoholics

  2016cites this paper
• Genes Associated with Alcohol Withdrawal

  2016cites this paper
• Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans

  2016cites this paper
• Dynorphin A analogs for the treatment of chronic neuropathic pain.

  2016cites this paper
• The Widely Available Hallucinogenic Plant Salvia divinorum and Its Main Component, Salvinorin A

  2016cites this paper
• Does the combination of buprenorphine/naltrexone have antidepressant efficacy in animal models?

  2016cites this paper
• Discriminative Stimulus Properties of Opioid Ligands: Progress and Future Directions.

  2016cites this paper
• Central Analgesic Activity

  2016cites this paper
• Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders

  2015cites this paper
• Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans

  2015cites this paper
• Opioid receptors: methods for detection and their modes of actions in the eye.

  2015cites this paper
• Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies

  2015cites this paper
• Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders

  2015cites this paper
• Investigational drugs under development for the treatment of PTSD

  2015cites this paper
• Sex Differences in Kappa Opioid Receptor Function and Their Potential Impact on Addiction

  2015cites this paper
• Novel fluoroalkyl derivatives of selective kappa opioid receptor antagonist JDTic: Design, synthesis, pharmacology and molecular modeling studies.

  2015cites this paper
• Salvinorin-A induces intense dissociative effects , blocking external sensory perception and modulating interoception and sense of body ownership in humans Regular research article

  2015influential citation
• Drug effects on responses to emotional facial expressions: recent findings

  2015cites this paper
• Bioinformatics and evolution of vertebrate nociceptin and opioid receptors.

  2015cites this paper
• Activation of κ-opioid receptor by U50,488H improves vascular dysfunction in streptozotocin-induced diabetic rats

  2015cites this paper
• Contribution of Opioid and Stress Systems to Impulsive Action in Rodent Models

  2015cites this paper
• Biased agonism at kappa opioid receptors: Implication in pain and mood disorders.

  2015cites this paper
• An in vitro analysis of striatal microcircuitry

  2015cites this paper
• Opioid partial agonist buprenorphine dampens responses to psychosocial stress in humans.

  2015cites this paper
• Predicted Structures for Kappa Opioid G-Protein Coupled Receptor Bound to Selective Agonists

  2015cites this paper
• Kappa Opioid Receptor Agonist and Brain Ischemia.

  2014influential citation
• Association of in vivo κ-opioid receptor availability and the transdiagnostic dimensional expression of trauma-related psychopathology.

  2014cites this paper
• The role of the opioid system in alcohol dependence

  2014cites this paper
• Roles of Central Opioid Receptor Subtypes in Regulating Itch Sensation

  2014cites this paper
• The Association of Genetic Polymorphisms in the &kgr;-Opioid Receptor 1 Gene With Body Weight, Alcohol Use, and Withdrawal Symptoms in Patients With Methadone Maintenance

  2014cites this paper
• Kinetic Modeling of 11C-LY2795050, A Novel Antagonist Radiotracer for PET Imaging of the Kappa Opioid Receptor in Humans

  2014cites this paper